JWM
EBS icon

JPL Wealth Management’s Emergent Biosolutions EBS Stock Holding History

JPL Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Buy
+8
New +$67 ﹤0.01% 1674

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

JPL Wealth Management's EBS Position: Q2 2026 in Review

JPL Wealth Management opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 8 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #1674 among its holdings.

195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • JPL Wealth Management held 8 shares of Emergent Biosolutions worth $68 as of Q2 2026.
  • Emergent Biosolutions was a new JPL Wealth Management position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1674 holding.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.